載入...
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
BACKGROUND: Four nonvitamin K antagonist oral anticoagulants (NOACs) are approved for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of venous thromboembolism. These include the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors...
Na minha lista:
| 發表在: | Crit Care |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034528/ https://ncbi.nlm.nih.gov/pubmed/27659071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1422-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|